Biocon Biologics concludes integration of acquired biosimilars business in 120 countries
Pharmaceutical giants Biocon Biologics has successfully completed the transition of its acquired biosimilars business in 120 countries across advanced and emerging markets, a year ahead of schedule, an official release stated on Monday.…